Cached score snapshot

US.MCK · McKesson Corporation

110分制 64.2/110；5D動能v2 7/50；排序分 71.2/160

Back to ranking Open volume snapshot

Ranking score 71.2/160

Main score 64.2/110

5D momentum v2 7/50

Rank #98

Setup grade F 30.8

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 30.8 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.479 · anchors 120	+1.90%	-1.40% / +2.52%	62.5%	5%	Actual +4.40% · vs median +2.50% · inside 25-75 band
30D observation	+8.04%	+2.24% / +12.34%	77.5%	17.5%	Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160	+0.71%	-1.60% / +2.69%	57.5%	5.6%	Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-05-28 → 2026-10-02 · 148 archived points · 3 Improving turn signal · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 71.2

Display grade 觀望

Model version cursor_18_27_news_v2_160

Main score 64.2/110 (觀望)

5D momentum v2 7/50 (弱)

Score with momentum v2 71.2/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 864.609

ma50 821.252

close 858.9

prevClose 838.75

avgVolume20 1049770

volumeRatio 1.51

changePercent 2.4

Metrics snapshot

close 858.9

volume 1580600

changePercent 2.4

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 64.2/110

Main rating 觀望

5D momentum v2 7/50

Score with momentum v2 71.2/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好

Dimension score 3.6/5

Dimension grade 良好

Sub-items

pbPoints 0

pePoints 0.4

epsPoints 0.75

roePoints 0

debtPoints 0.5

marginPoints 0

turnoverUsdM 1357.5774

volumePoints 0.5

revenuePoints 0.6

dividendPoints 0.3

marketCapPoints 0.5

資金流 — 10/20 · 較差

Dimension score 10/20

Dimension grade 較差

Sub-items

cmfPoints 0.8

mfiPoints 2.4

obvPoints 4

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.MCK

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 8.2/15 · 較差

Dimension score 8.2/15

Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred

vixClose 16.01

trend

score 3

details

qqq

ma20 709.1885

ma50 713.4416

name QQQ

close 713.44

points 1

spy

ma20 762.327

ma50 751.7496

name SPY

close 765.72

points 2

source twelvedata+fred

atrPct 3.401

atrPoints 2

cciPoints 0.8

vixPoints 2.4

marketTrendPoints 3

催化劑 — 10/20 · 較差

Dimension score 10/20

Dimension grade 較差

Sub-items

catalyst

score 10

details

source finnhub_news_keyword_model

articleCount 8

catalystCount 2

catalystPoints 10

風險管理 — 6.7/10 · 一般

Dimension score 6.7/10

Dimension grade 一般

Sub-items

position

score 1.5

details

atrPct 3.401

turnoverUsdM 1357.5774

liquidityPoints 0.8

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.MCK

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 800.4772

strength_details

ma_score 1.5

atr_score 1

rsi_score 2

macd_score 1.5

volume_score 2

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.8

take_profit_price 919.0268

target_multiplier 1.9

technical_strength 1.63

take_profit_percent 7

positionPoints 1.5

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.802

diversificationPoints 2

技術信號 — 19.7/30 · 一般

Dimension score 19.7/30

Dimension grade 一般

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 2.4

vcpPoints 1.6

macdPoints 2.4

vcpPayload

vcp_pass false

vcp_score 1.6

vcp_reason 波幅收縮(14.2%→7.4%)；站上MA50；Ready=N；Confirm=N

vcp_metrics

up_days 4

vol_ref 952933.3333

down_days 5

vcp_ready false

above_ma50 true

avg_vol_10 913170

avg_vol_20 1011930

avg_vol_30 952933.3333

range_pct_10 0.0737

range_pct_20 0.1183

range_pct_30 0.142

up_expand_ok false

lookback_used 59

near_20d_high true

contraction_ok true

down_shrink_ok false

up_expand_days 0

breakout_20d_ok false

vol_ratio_10_30 0.9583

dist_to_20d_high 0.0587

down_shrink_days 2

breakout_level_20d 912.5

vcp_breakout_confirm false

contraction_ratio_10_30 0.5195

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction true

kdjAdxPoints 0.5

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 0.8

shortMacdPoints 0.4

volConfirmPoints 1

volumePointsTechnical 1.2

情緒分析 — 6/10 · 一般

Dimension score 6/10

Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model

articleCount 8

negativeHits 0

positiveHits 5

sentimentScoreRaw 1.5

sentimentData

raw {"id":141279873,"url":"https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...","category":"company","datetime":1787275175,"headline":"McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"}, {"id":141279875,"url":"https://finnhub.io/api/news?id=f6035c2fee2c59ca1eaac8e5da967b709784076bca00286133a3da05dae0cb0b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...","category":"company","datetime":1787256543,"headline":"McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?"}, {"id":141258800,"url":"https://finnhub.io/api/news?id=bdb7e234a55d9cb334bafa47adbce8dc37ba2ded4a75ace86531b8150354fc20","image":"","source":"Fintel","related":"MCK","summary":"","category":"company","datetime":1787190141,"headline":"RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform Recommendation"}, {"id":141279874,"url":"https://finnhub.io/api/news?id=71e8053143691ce56fa051f1633b66dd2fc4e0397c0f77a7befeda58c6e547db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers & services stocks fared in Q2, starting with McKesson (NYSE:MCK).","category":"company","datetime":1787146682,"headline":"Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks"}, {"id":141157482,"url":"https://finnhub.io/api/news?id=0a358d781b15edfdd9e8d08f722aa5155ec12f731cd9f35d61f78a4ed69b80a1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running share repurchase program and raised adjusted earnings guidance, highlighting management’s confidence in specialty and oncology growth, technology and AI investments, and the...","category":"company","datetime":1786180297,"headline":"How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story"}, {"id":141149554,"url":"https://finnhub.io/api/news?id=05b594034734df0805d0360650dd626b9ea4065fe219f8f657040e1aac0a900c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) could produce exceptional returns because of its solid growth attributes.","category":"company","datetime":1786121103,"headline":"McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why"}, {"id":141137317,"url":"https://finnhub.io/api/news?id=800e586663a06c21846fb4704cde171e522540f493e9141574d3def76d3d7334","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.","category":"company","datetime":1786030860,"headline":"MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised"}, {"id":141135594,"url":"https://finnhub.io/api/news?id=688c9cef3366902114ebb4a2dd2eead7afd75544ec841ba4439fd53ddcd80354","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.","category":"company","datetime":1786024800,"headline":"MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise"}

raw_source {"id":141279873,"url":"https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...","category":"company","datetime":1787275175,"headline":"McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"}, {"id":141279875,"url":"https://finnhub.io/api/news?id=f6035c2fee2c59ca1eaac8e5da967b709784076bca00286133a3da05dae0cb0b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...","category":"company","datetime":1787256543,"headline":"McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?"}, {"id":141261329,"url":"https://finnhub.io/api/news?id=0bcc4b756c6d1ebb9c1d9f3ee76fbdf22f5f0eca89a7e45fd098bfb7d6ddce91","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157585497/image_2157585497.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Net of fees, GRW delivered a return of +17.32% in Q2 2026, compared to the S&P 500 Index's return of +15.20%.","category":"company","datetime":1787217000,"headline":"TCW Durable Growth ETF Q2 2026 Performance Update"}, {"id":141258800,"url":"https://finnhub.io/api/news?id=bdb7e234a55d9cb334bafa47adbce8dc37ba2ded4a75ace86531b8150354fc20","image":"","source":"Fintel","related":"MCK","summary":"","category":"company","datetime":1787190141,"headline":"RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform Recommendation"}, {"id":141279876,"url":"https://finnhub.io/api/news?id=80e2683d6b03e9856102f88928d0b33f293bf6830fce12c7e49c75c925df79ae","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.","category":"company","datetime":1787157180,"headline":"Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?"}, {"id":141255098,"url":"https://finnhub.io/api/news?id=407cd590acc44067e69ec21c3b5d573dbff31e348a254be4edac3e8cfcac88f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls","category":"company","datetime":1787150302,"headline":"Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls"}, {"id":141279874,"url":"https://finnhub.io/api/news?id=71e8053143691ce56fa051f1633b66dd2fc4e0397c0f77a7befeda58c6e547db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers & services stocks fared in Q2, starting with McKesson (NYSE:MCK).","category":"company","datetime":1787146682,"headline":"Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks"}, {"id":141257551,"url":"https://finnhub.io/api/news?id=f6172b7c49124c0d4ec9fce8c5738b4d9d405e7db8353fc6b685e4509c75e306","image":"","source":"Benzinga","related":"MCK","summary":"Barclays analyst Glen Santangelo maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $925 to $1000.","category":"company","datetime":1787134773,"headline":"Barclays Maintains Overweight on McKesson, Raises Price Target to $1000"}, {"id":141257552,"url":"https://finnhub.io/api/news?id=6be89915164eaea69f703cb5c151a416184f8f61bf8d3c61215b0822d48fd47d","image":"","source":"Benzinga","related":"MCK","summary":"RBC Capital analyst Ryan Halsted initiates coverage on McKesson (NYSE:MCK) with a Sector Perform rating and announces Price Target of $845.","category":"company","datetime":1787133051,"headline":"RBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845"}, {"id":141279877,"url":"https://finnhub.io/api/news?id=c47505c3dc9586b3a6348210ab896b422c8c06eda61b4c18fa117bc974b4f9e2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.","category":"company","datetime":1787077380,"headline":"OPKO Health Secures $125 Million Financing Against Mazdutide Royalties"}, {"id":141223241,"url":"https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.","category":"company","datetime":1786740389,"headline":"AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":141237778,"url":"https://finnhub.io/api/news?id=367a84c2f8076f5a8bad9804ededf729b3319df5dfda2f5bb74e17f5d37735d7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.","category":"company","datetime":1786725360,"headline":"Reasons to Hold Hinge Health Stock in Your Portfolio for Now"}, {"id":141237779,"url":"https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.","category":"company","datetime":1786725300,"headline":"SOLV Plans Health Information Systems Business Spinoff to Drive Growth"}, {"id":141215404,"url":"https://finnhub.io/api/news?id=beb9b099af96d85f171d75a1ec7e33b07f1b4f81a4d3a80843d5472a77c0205e","image":"","source":"SeekingAlpha","related":"MCK","summary":"","category":"company","datetime":1786685700,"headline":"Allspring Large Cap Growth Fund Q2 2026 Performance Update"}, {"id":141200621,"url":"https://finnhub.io/api/news?id=a08e7c7fa18be82606ea2feeb7ddeeada1626fe5e95e301c926252196ccedab8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie commands a premium valuation for its specialty drug pipeline, while CVS Health trades at a discount despite managing 37 million medical members.","category":"company","datetime":1786481221,"headline":"AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":141201489,"url":"https://finnhub.io/api/news?id=e53a74fb978cb94b10738c9262b2a96baa6fac4eef3538f1a98cc3c9da000745","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment. For the q","category":"company","datetime":1786467870,"headline":"Cardinal Health Q4 Earnings Call Highlights"}, {"id":141201490,"url":"https://finnhub.io/api/news?id=b27d87e3c8947f158bf4d832fe91f3e13a1b1c088d17bd7f1566ddeb622996ec","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall. Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point. Cencora, another big S&P 500 drug distributor, also is near a buy point, but MCK stock may be the strongest of the three.","category":"company","datetime":1786454176,"headline":"S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results"}, {"id":141185344,"url":"https://finnhub.io/api/news?id=36e70aefff215f1037c8bea30b9efe2b8c455a038d191cea49c8576b1e70276b","image":"","source":"Benzinga","related":"MCK","summary":"Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and raises the price target from $812 to $933.","category":"company","datetime":1786438791,"headline":"Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933"}, {"id":141177635,"url":"https://finnhub.io/api/news?id=2e87455abaf1fa312c423f3bfe57322bf443a81c6e419773c587559f5d9f5133","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.","category":"company","datetime":1786382940,"headline":"QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered"}, {"id":141177636,"url":"https://finnhub.io/api/news?id=ffdfab5d91e411887bc6414fe5e00badc391012530468522e6572447588ee92f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.","category":"company","datetime":1786382820,"headline":"Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline"}, {"id":141160721,"url":"https://finnhub.io/api/news?id=4d55152f0db1c1fa5527adfeaf586f1bb8bf0d0827f7c70061f163d0723eb98f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (NYSE:MCK) reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook. Revenue rose 8% to $105.4 billion, while adjuste","category":"company","datetime":1786212231,"headline":"McKesson Q1 Earnings Call Highlights"}, {"id":141158590,"url":"https://finnhub.io/api/news?id=e1de4277f5c22ac4c0037ee71ee9c2226bd01f2d336d1abf5c27b1908b45915c","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305098938/image_1305098938.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Weekly dividend stock update: 24 hikes, 1 cut. Read to see top raises like FIX & MCK, HONâs spinoff impact, and how to spot safe income.","category":"company","datetime":1786184967,"headline":"Dividend Announcements: July 18-24, 2026"}, {"id":141157482,"url":"https://finnhub.io/api/news?id=0a358d781b15edfdd9e8d08f722aa5155ec12f731cd9f35d61f78a4ed69b80a1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running share repurchase program and raised adjusted earnings guidance, highlighting management’s confidence in specialty and oncology growth, technology and AI investments, and the...","category":"company","datetime":1786180297,"headline":"How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story"}, {"id":141157906,"url":"https://finnhub.io/api/news?id=fab1c782cbda61816d37a0ae7c11e896000944385900ca33ac459cfdbb26e466","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230977259/image_2230977259.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"McKesson's Q1 earnings: EPS up 20%, revenue +7.7%, FY27 guidance raised. Click here to read more about MCK.","category":"company","datetime":1786176000,"headline":"McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)"}, {"id":141152474,"url":"https://finnhub.io/api/news?id=3852ba4223d6f6fd4381be34a82f8c1b6dd45b23181cf2e6ab311afb3d93f615","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.","category":"company","datetime":1786135497,"headline":"AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?"}, {"id":141151124,"url":"https://finnhub.io/api/news?id=d7465a2a4c88ee05863f3b79d5beec80125a4c5b3f1728075ee3ed1c26c3ad57","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.","category":"company","datetime":1786126800,"headline":"Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?"}, {"id":141151125,"url":"https://finnhub.io/api/news?id=0854f9893f7e0124ebd598160832596723151b50db3780060288d2e8256a7c06","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.","category":"company","datetime":1786125420,"headline":"10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up"}, {"id":141151126,"url":"https://finnhub.io/api/news?id=cfab742cf05cd6088afc2f50d6af7fb553f338ccdbaf70bfd1cdcd0559e40570","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"RGTI's Q2 revenues surge 185.3% and beat estimates, but widening losses and higher R&D and SG&A costs continue to pressure profitability.","category":"company","datetime":1786125300,"headline":"Rigetti Q2 Earnings Miss Estimates on Higher Costs, Revenue Beat"}, {"id":141149554,"url":"https://finnhub.io/api/news?id=05b594034734df0805d0360650dd626b9ea4065fe219f8f657040e1aac0a900c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) could produce exceptional returns because of its solid growth attributes.","category":"company","datetime":1786121103,"headline":"McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why"}, {"id":141159495,"url":"https://finnhub.io/api/news?id=9ffb7fecb0f501883098779ae65df01fc0dcd39cc25eb11b2d6bf358942a43ff","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536","source":"Benzinga","related":"MCK","summary":"McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.04% on an annualized basis producing an average annual return of 34.84%. Currently, McKesson has a market capitalization of $101.38 billion.","category":"company","datetime":1786119325,"headline":"$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today"}, {"id":141148240,"url":"https://finnhub.io/api/news?id=1def74c37e95fb5383501555aa63fc8a7abb1562fe6f79afae08e538c51ffed9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1786108503,"headline":"Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?"}, {"id":141140627,"url":"https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.","category":"company","datetime":1786038780,"headline":"Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"}, {"id":141140628,"url":"https://finnhub.io/api/news?id=a8b9dcae545cc5c62870f85c5a89bc5758dc075833203dde38abaea6245b92f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.","category":"company","datetime":1786035840,"headline":"PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut"}, {"id":141137316,"url":"https://finnhub.io/api/news?id=f23c7f57565c87589923985dcfb23a36115479fe932f711cc0df05b80818daf2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.","category":"company","datetime":1786033860,"headline":"LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised"}, {"id":141147900,"url":"https://finnhub.io/api/news?id=e42c57bcc23d4c025cac49bfa0346608180e95cfd8fa94993d84f176c4078ee0","image":"","source":"Benzinga","related":"MCK","summary":"TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $989 to $1006.","category":"company","datetime":1786031449,"headline":"TD Cowen Maintains Buy on McKesson, Raises Price Target to $1006"}, {"id":141137317,"url":"https://finnhub.io/api/news?id=800e586663a06c21846fb4704cde171e522540f493e9141574d3def76d3d7334","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.","category":"company","datetime":1786030860,"headline":"MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised"}, {"id":141147901,"url":"https://finnhub.io/api/news?id=57909521d0c5f1ad27c8c7cd26201167f0969b5d46730032b4eb69edeb502361","image":"","source":"Benzinga","related":"MCK","summary":"UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1050 to $1080.","category":"company","datetime":1786030450,"headline":"UBS Maintains Buy on McKesson, Raises Price Target to $1080"}, {"id":141135594,"url":"https://finnhub.io/api/news?id=688c9cef3366902114ebb4a2dd2eead7afd75544ec841ba4439fd53ddcd80354","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.","category":"company","datetime":1786024800,"headline":"MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise"}, {"id":141134168,"url":"https://finnhub.io/api/news?id=43b6a86813caef07467b33bc73f0cc2783705a8dc341743143ddb802b51d6bfe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"NEW YORK, August 06, 2026--Leap, the healthcare company making specialty medicine more affordable and easier to access, today announced the appointment of Christine Hummel as Senior Vice President of Manufacturer and Specialty Network Partnerships. In this role, she will lead Leap's strategy and partnerships across pharmaceutical manufacturers and specialty care networks, helping expand access to specialty therapies through more transparent and efficient models of care.","category":"company","datetime":1786021200,"headline":"Leap Expands Manufacturer & Specialty Network Partnerships with Appointment of Industry Executive Christine Hummel"}, {"id":141137787,"url":"https://finnhub.io/api/news?id=a73436ca295abf1de7d9c8dd5ce945af1b0ef6be9e55b065e2e5fc02892b7749","image":"","source":"Benzinga","related":"MCK","summary":"Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $860 to $1000.","category":"company","datetime":1786015827,"headline":"Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1000"}, {"id":141131696,"url":"https://finnhub.io/api/news?id=5e849f33a30c41b4ca74705591359f68c72fb6a6dd8b4a7c2d3d78f79efec312","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson Corp (MCK) delivered an 8% revenue increase to $105.4 billion and a 20% adjusted EPS surge, prompting a full-year guidance raise and a 15% dividend boost.","category":"company","datetime":1785993296,"headline":"McKesson Corp (MCK) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth and Raised ..."}, {"id":141130794,"url":"https://finnhub.io/api/news?id=0a850ca78cc7e37d25c8f624d58ecd116d71c8379534dab0cb095f3248372dfe","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"MCK","summary":"2026-08-05. The following slide deck was published by McKesson Corporation in conjunction with their 2027 Q1 earnings call.","category":"company","datetime":1785972649,"headline":"McKesson Corporation 2027 Q1 - Results - Earnings Call Presentation"}, {"id":141129269,"url":"https://finnhub.io/api/news?id=ff081edfb0df7029814b96a8f351f77f0883e8cf8768832ad40be18385153566","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) delivered earnings and revenue surprises of +5.19% and +0.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785967816,"headline":"McKesson (MCK) Q1 Earnings and Revenues Top Estimates"}, {"id":141129271,"url":"https://finnhub.io/api/news?id=cf6cc63b667f0870660b51f8e2e87fbf1a3579d7836911847ae6330c723cc033","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","category":"company","datetime":1785967203,"headline":"McKesson (MCK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates"}, {"id":141129972,"url":"https://finnhub.io/api/news?id=9f59631d212bc4e1f1055fc6d749a0785b9d8187697a5d4c2afa491afc330b9a","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"MCK","summary":"McKesson Corporation (MCK) Q1 2027 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsPaula AdkisonBrian Tyler - CEO & ChairmanKenny Cheung -...","category":"company","datetime":1785966004,"headline":"McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript"}, {"id":141126827,"url":"https://finnhub.io/api/news?id=0c31fe0b2d0caab81d508e5fdaea005a58287c2047d6405ce71ba4ef83761794","image":"https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp","source":"ChartMill","related":"MCK","summary":"As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.","category":"company","datetime":1785963901,"headline":"Stay updated with the S&P500 stocks that are on the move in today's after-hours session."}, {"id":141127546,"url":"https://finnhub.io/api/news?id=bcecb40436a3b28ccff2c7297ffeaa92d90921bca447a797e27b95e6d18108d3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Healthcare distributor and services company McKesson (NYSE:MCK) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.7% year on year to $105.4 billion. Its non-GAAP profit of $9.93 per share was 4.1% above analysts’ consensus estimates.","category":"company","datetime":1785961145,"headline":"McKesson’s (NYSE:MCK) Q2 CY2026 Sales Top Estimates"}, {"id":141127547,"url":"https://finnhub.io/api/news?id=abf8dbc88f5894982fb638c2fb3764b940a7daae809e5be48fce0e666ccc4989","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"IRVING, Texas, August 05, 2026--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.","category":"company","datetime":1785960600,"headline":"McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance"}, {"id":141125706,"url":"https://finnhub.io/api/news?id=323e5a3f9c5dd535eafdd88ad8552039eeecd9956c9b18925cca11db56bff5ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"A few sectors have dominated the market this year, and healthcare isn’t one of them. Many stocks in the sector look ready to gain.","category":"company","datetime":1785958260,"headline":"Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy."}, {"id":141125845,"url":"https://finnhub.io/api/news?id=1f072d8bc81262c58fcde9ca14f0cd390a156475a76a63fa82afa3bf37326bfe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.","category":"company","datetime":1785951720,"headline":"TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract"}, {"id":141124354,"url":"https://finnhub.io/api/news?id=3c99f0ca4df1360198bfda8776337250d51ac456a32bc832bac0b78ca6f14858","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance reinforce business momentum.","category":"company","datetime":1785948000,"headline":"HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up"}, {"id":141128229,"url":"https://finnhub.io/api/news?id=3a61b69f67aa929b9980aa22c17447a78ed891765ef84087244fc7252e7c0df0","image":"","source":"Benzinga","related":"MCK","summary":"McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 analyst estimate. sees sales of $423.601 billion-$439.739 billion vs $431.419 billion analyst estimate.","category":"company","datetime":1785946367,"headline":"McKesson Raises FY2027 Adj EPS Guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 Est; Sees Sales $423.601B-$439.739B vs $431.419B Est"}, {"id":141128230,"url":"https://finnhub.io/api/news?id=a7cb6eb9aa91c66396e41a053e3ae42514dc2810013c434a74592a0bcf5fa5bc","image":"","source":"Benzinga","related":"MCK","summary":"McKesson (NYSE:MCK) reported quarterly earnings of $9.93 per share which beat the analyst consensus estimate of $9.54 by 4.09 percent. This is a 20.22 percent increase over earnings of $8.26 per share from the same","category":"company","datetime":1785946294,"headline":"McKesson Q1 Adj. EPS $9.93 Beats $9.54 Estimate, Sales $105.380B Beat $103.738B Estimate"}, {"id":141122656,"url":"https://finnhub.io/api/news?id=026d8fb37247e734556ab139d7617d44722f4e154e1c54607e4041ad152a13a1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.","category":"company","datetime":1785941400,"headline":"COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised"}, {"id":141122657,"url":"https://finnhub.io/api/news?id=d65126c035551814d108e50a1313d81a1237d5b5ba6733964cc3b8dad767605a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.","category":"company","datetime":1785941340,"headline":"FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand"}, {"id":141121177,"url":"https://finnhub.io/api/news?id=23e6ddf098968bb77ad4c266e778419394fc5af585454c4207229c455f8f2bdd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"The benchmark US stock measures were trending higher in Wednesday's premarket activity amid growing","category":"company","datetime":1785932158,"headline":"Stocks Rise Pre-Bell Amid Growing Hopes for Hormuz Deal; Traders Await More Corporate Earnings"}, {"id":141114964,"url":"https://finnhub.io/api/news?id=3a27c79bdda7dbd1818b7e5a6ed33774efec5c2b5603c9fd4a49454d569f3183","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Revvity beats Q2 earnings and sales estimates as Diagnostics growth, wider margins and strong cash flow support a higher 2026 outlook.","category":"company","datetime":1785870540,"headline":"RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up"}, {"id":141114965,"url":"https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.","category":"company","datetime":1785870480,"headline":"What's in Store for These 4 Healthcare Companies This Earnings Season?"}, {"id":141113306,"url":"https://finnhub.io/api/news?id=93e3024cc729afbadc0388f46416383251b5c154792cb2c44fa43872b0efef0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, policy and integration risks test the rebound case.","category":"company","datetime":1785864120,"headline":"BTSG Drops 18.1% in One Week as Growth Meets Fresh Valuation Risks"}, {"id":141112034,"url":"https://finnhub.io/api/news?id=29220b2023579682d098f84e1a9bd930eeb6b970fa72c6152de3c809aefed06f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.","category":"company","datetime":1785862680,"headline":"Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up"}, {"id":141103123,"url":"https://finnhub.io/api/news?id=956f1718fa4a9368b5b1e1c2d0314e3d2f1156a72ea5cdc41fba63ace48f774f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as pricing dynamics may temper revenues.","category":"company","datetime":1785783300,"headline":"Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?"}, {"id":141101012,"url":"https://finnhub.io/api/news?id=997f5ef6b2549b82d642e99554c1aea576c8afc47908049915f352f11bb26752","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"BTSG's Q2 earnings and revenues beat estimates as pharmacy and provider growth drive margin gains and a higher 2026 outlook.","category":"company","datetime":1785773520,"headline":"BrightSpring Q2 Earnings Beat on Specialty Growth, '26 View Raised"}, {"id":141108755,"url":"https://finnhub.io/api/news?id=a08b99fb7096703dfb31cfc5e4f1ad7c2d68a1f75c321c5bf42201e21fe53b69","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector.","category":"company","datetime":1785764700,"headline":"3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles"}, {"id":141090737,"url":"https://finnhub.io/api/news?id=4485177046a32c74935a58c2263e20d35d6b0f20123beaf5636edf36703d37c2","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1217747083/image_1217747083.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Altria Group is poised to announce its 56th consecutive annual dividend increase in August. Check out the dividend increases here.","category":"company","datetime":1785624101,"headline":"Altria Among 7 Dividend Kings To Announce Annual Dividend Increases In August"}, {"id":141092901,"url":"https://finnhub.io/api/news?id=1cc922ced795d9da440e685882a8ed10b093e94b40fc4102622ab8df73130eda","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"A weekly roundup covering Magnificent Seven earnings, Fed rate pauses, U.S.-Iran tensions, and MarketBeat analysts' takes on stocks including Microsoft, Alphabet, Broadcom, Tesla, and UnitedHealth.","category":"company","datetime":1785582000,"headline":"MarketBeat Week in Review – 07/27- 07/31"}, {"id":141082663,"url":"https://finnhub.io/api/news?id=b33047fe895cae4d7a41b3346f7bc9c963ecde60ea4abc0a175bec3123356b5e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"BCE (TSX: BCE) (NYSE: BCE) today announced the appointment of Rebecca McKillican as a director of BCE Inc. and Bell Canada.","category":"company","datetime":1785528900,"headline":"Rebecca McKillican joins the Board of Directors of BCE Inc."}, {"id":141081614,"url":"https://finnhub.io/api/news?id=d255bc31c026370e4f43efbdda0092a70757d40c305c682c668d4ecc02048759","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.","category":"company","datetime":1785519660,"headline":"DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise"}, {"id":141080381,"url":"https://finnhub.io/api/news?id=c1245c5746c22ff46ef9ac1ca560e75935767219c3b020b02059cac810c7e881","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.","category":"company","datetime":1785510480,"headline":"MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised"}, {"id":141079102,"url":"https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.","category":"company","datetime":1785504660,"headline":"SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"}, {"id":141079111,"url":"https://finnhub.io/api/news?id=1075a796802e71cf0015696da984fb33e290de2ef9e726d4e035ee3fe6f87cab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Get a deeper insight into the potential performance of McKesson (MCK) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.","category":"company","datetime":1785503702,"headline":"Curious about McKesson (MCK) Q1 Performance? Explore Wall Street Estimates for Key Metrics"}, {"id":141072969,"url":"https://finnhub.io/api/news?id=a800a1b5e3d0fd3cee3e94630f0ecf458df676d9d35e60bcfa5793e773f0ebcf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"In the most recent trading session, McKesson (MCK) closed at $865.51, indicating a -2.59% shift from the previous trading day.","category":"company","datetime":1785448205,"headline":"McKesson (MCK) Stock Dips While Market Gains: Key Facts"}, {"id":141069866,"url":"https://finnhub.io/api/news?id=0dfe3261d572d799bd0afc21d1b7620e68822a55e077b34e774063c0083f6990","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.","category":"company","datetime":1785430140,"headline":"CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands"}, {"id":141068410,"url":"https://finnhub.io/api/news?id=158f7b2c996c478551835b9450571218c59e03e29195ae6524c63f0ad04ffc1f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.","category":"company","datetime":1785429960,"headline":"Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised"}, {"id":141068411,"url":"https://finnhub.io/api/news?id=0007ffe0216e700b6c8ed0b3e1049e7206b7730a714da3b4daae9f8b75ec010f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.","category":"company","datetime":1785427320,"headline":"BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract"}, {"id":141068412,"url":"https://finnhub.io/api/news?id=cc292e3b8f12ff007275fcb1af654d34bc6fe0a8a71b1d867b4bfd95cdd330fc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"GKOS' Q2 loss narrows as revenues jump 50% on iDose TR and Epioxa growth, lifting its 2026 sales outlook and shares by 9.8%.","category":"company","datetime":1785426900,"headline":"Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up"}, {"id":141059800,"url":"https://finnhub.io/api/news?id=b145bdf9f5394b56227ec59e5e7b0f8bff3a4c840be8118d8207d93894c18a09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Align Technology (ALGN) delivered earnings and revenue surprises of +3.13% and +0.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785360302,"headline":"Align Technology (ALGN) Q2 Earnings and Revenues Top Estimates"}, {"id":141055862,"url":"https://finnhub.io/api/news?id=d2c593c9349957b3ca16152323c967c4417d3ab3f9db8797978f488a55bb6f6e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.","category":"company","datetime":1785339720,"headline":"GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"}, {"id":141055863,"url":"https://finnhub.io/api/news?id=dc6b208f3d8cb61b19b3c297a8cc56c2951996a4af7af738c66e92cd98982229","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.","category":"company","datetime":1785337380,"headline":"Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"}, {"id":141054255,"url":"https://finnhub.io/api/news?id=c07c6878fb8ef451d86fccafb8bd6bcd12ec58f8373bdf0ea9da5520bdc03e5c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1785333626,"headline":"McKesson (MCK) Earnings Expected to Grow: Should You Buy?"}, {"id":141046401,"url":"https://finnhub.io/api/news?id=32ad537cf749428c45d48370b3a6ea3ee5ef6bbb0ca881255ba5054d1decc3b0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.","category":"company","datetime":1785257820,"headline":"Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"}, {"id":141046402,"url":"https://finnhub.io/api/news?id=6a65cd8bb4225e38749850240bc29db3c65aae000cf5cf660f47852c738148f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.","category":"company","datetime":1785257700,"headline":"OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates"}, {"id":141033957,"url":"https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.","category":"company","datetime":1785160469,"headline":"The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"}, {"id":141033964,"url":"https://finnhub.io/api/news?id=fd308767b5de2c6bbd78aa55718c495e1be0694fd3a2087679a5015086eaaedb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?","category":"company","datetime":1785159003,"headline":"Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?"}, {"id":141033965,"url":"https://finnhub.io/api/news?id=5d7090a4fb695f255effb47da586d72dcf54b4a024ad6a80984d2819806eaa0c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.","category":"company","datetime":1785158640,"headline":"MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access"}, {"id":141020306,"url":"https://finnhub.io/api/news?id=73ec387978594516cefd80c1f0e8166176ea7c11b61ab76ccd49db0b05476065","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson (MCK) has announced a quarterly dividend of $0.94 per share, payable on October 1, 2026. Both the ex dividend and record dates are set for September 1, 2026, drawing fresh attention to the stock. See our latest analysis for McKesson. At a latest share price of $840.90, McKesson has seen a 1 day share price return of 1.99% and a 1 month share price return of 9.70%, while its 1 year total shareholder return of 18.61% and 5 year total shareholder return of 323.86% indicate solid longer...","category":"company","datetime":1785020887,"headline":"McKesson (MCK) Declares Quarterly Dividend, Is The Stock Still Undervalued?"}, {"id":141015640,"url":"https://finnhub.io/api/news?id=cfff6f73a99eed00740246c232ba2122851845a21a2f029f0288fd135c2935e8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"McKesson stock has logged a very strong 323.9% return over the past five years, yet the latest valuation checks still flag it as screening on the cheap side. This raises the question of how much of the story is already reflected in the current US$840.90 share price. Over five years, McKesson has returned 323.9%, which puts long term holders in a strong position and makes today’s entry point more sensitive to the valuation starting point. For valuation, the key support is the company’s role...","category":"company","datetime":1784977846,"headline":"McKesson (MCK) Stock May Still Be A Bargain After A 324% Run"}, {"id":141014631,"url":"https://finnhub.io/api/news?id=260949078611a1976e37ca06fdaa7e41273b6effb3c5ecf71d425036d789c368","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"Earlier this week, McKesson Corporation announced a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend and record date. This higher payout highlights how McKesson is combining dividend growth with its existing share repurchase efforts, reinforcing management’s confidence in the company’s earnings power. Against this backdrop of a higher quarterly dividend, we’ll now examine how the announcement interacts with...","category":"company","datetime":1784959804,"headline":"Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK)"}, {"id":141011008,"url":"https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"MCK","summary":"Get the weekly dividend update for Champions, Contenders & Challengersâread about the dividend changes, upcoming ex-dividend dates and pay dates here.","category":"company","datetime":1784916411,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"}, {"id":141011728,"url":"https://finnhub.io/api/news?id=5aebcf7f9b3006eddba94bd090b7f1e841c15c773ab1a11b67e7a7db30d25b13","image":"","source":"Benzinga","related":"MCK","summary":"Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $945 to $1000.","category":"company","datetime":1784906497,"headline":"Citigroup Maintains Buy on McKesson, Raises Price Target to $1000"}, {"id":141007920,"url":"https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.","category":"company","datetime":1784905740,"headline":"Here's Why You Should Add Cencora Stock to Your Portfolio Now"}, {"id":141007921,"url":"https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"MCK","summary":"RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.","category":"company","datetime":1784905500,"headline":"Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"}

data_source finnhub_news_keyword_model

article_count 8

negative_hits 0

positive_hits 5

recomputed_at_score true

sentiment_score_raw 1.5

source_article_count 91

discarded_article_count 70

sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 3.6 5/110 72% 3.6

資金流 10 20/110 50% 10

市場環境 8.2 15/110 54.67% 8.2

催化劑 10 20/110 50% 10

風險管理 6.7 10/110 67% 6.7

技術信號 19.7 30/110 65.67% 19.7

情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50

ret_5d -0.0116

max_score 50

max_total 50

raw_total 7

vcp_bonus 0

vol_ratio 1.562

ret_points 0

vol_points 6

range_ratio 1.1725

volat_points 0

day_range_pct 0.035

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 1

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.5

details

atrPct 3.401

turnoverUsdM 1357.5774

liquidityPoints 0.8

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.MCK

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 800.4772

strength_details

ma_score 1.5

atr_score 1

rsi_score 2

macd_score 1.5

volume_score 2

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.8

take_profit_price 919.0268

target_multiplier 1.9

technical_strength 1.63

take_profit_percent 7

positionPoints 1.5

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.802

diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 10/20分
市場環境分析總分: 8.2/15分
催化劑分析: 10/20分
風險管理總分: 6.7/10分
技術信號分析總分: 19.7/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 92.86

atr

atr 29.2114

rule ATR / current price; lower volatility scores higher

score 4

atr_pct 3.4

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value -50.82

cmf

rule Cursor_18.24 CMF bands

level 派發

score 2

value -0.1294

kdj

d 34.13

j 8.57

k 25.61

rule Cursor_18.24 K/D cross

score 0

signal 死叉

mfi

rule Cursor_18.24 MFI bands

level 平衡

score 6

value 57.41

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 10

trend 強流入

value -4850000

recentSlope -110340

previousSlope -256640

rsi

value 57.34

sar

rule Cursor_18.24 Parabolic SAR

score 8

trend 上升

value 824.4859

position SAR喺價下

distancePct 4.01

previousTrend 上升

ma50

value 821.252

macd

macd 9.4398

trend 中性偏多

signal 14.602

histogram -5.1622

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 865.5648

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 有量

ratio 1.51

score 6

avgVolume 1049770

currentVolume 1580600

derived

ma20 864.609

ma50 821.252

prevClose 838.75

avgVolume10 915010

avgVolume20 1049770

changePercent 2.4

avgVolumeForScore 1049770

ma_cross

ma20 864.609

ma50 821.252

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 863.709

prevMa50 819.8828

spreadPct 5.28

isVolumeBreakout true

bollinger

lower 827.0924

upper 902.1256

position 中間

rsi_short

value 51.36

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 1.51

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 3.4010244871108513,
        "turnoverUsdM": 1357.577371612,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MCK",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 800.4772,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.8,
      "take_profit_price": 919.0268,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 7
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.8020489742217025,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 71.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 64.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 864.609,
    "ma50": 821.252,
    "close": 858.9,
    "prevClose": 838.75,
    "avgVolume20": 1049770,
    "volumeRatio": 1.51,
    "changePercent": 2.4
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.01162253164556959,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.5619657486189755,
      "ret_points": 0,
      "vol_points": 6,
      "range_ratio": 1.1724718747461988,
      "volat_points": 0,
      "day_range_pct": 0.03497494388229262,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 71.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 8.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 54.67,
        "contribution": 8.2
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 6.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 67,
        "contribution": 6.7
      },
      {
        "raw": 19.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 65.67,
        "contribution": 19.7
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 64.2,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 8.2/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 6.7/10分",
      "技術信號分析總分: 19.7/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 3.6,
      "資金流": 10,
      "市場環境": 8.2,
      "情緒分析": 6,
      "技術信號": 19.7,
      "風險管理": 6.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.4,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 1357.577371612,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MCK",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.01
            }
          },
          "trend": {
            "score": 3,
            "details": {
              "qqq": {
                "ma20": 709.1885013500001,
                "ma50": 713.4416018399997,
                "name": "QQQ",
                "close": 713.44,
                "points": 1
              },
              "spy": {
                "ma20": 762.32700215,
                "ma50": 751.7496043999998,
                "name": "SPY",
                "close": 765.71997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.4010244871108513,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141279873,
                "url": "https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...",
                "category": "company",
                "datetime": 1787275175,
                "headline": "McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"
              },
              {
                "id": 141279875,
                "url": "https://finnhub.io/api/news?id=f6035c2fee2c59ca1eaac8e5da967b709784076bca00286133a3da05dae0cb0b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...",
                "category": "company",
                "datetime": 1787256543,
                "headline": "McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?"
              },
              {
                "id": 141258800,
                "url": "https://finnhub.io/api/news?id=bdb7e234a55d9cb334bafa47adbce8dc37ba2ded4a75ace86531b8150354fc20",
                "image": "",
                "source": "Fintel",
                "related": "MCK",
                "summary": "",
                "category": "company",
                "datetime": 1787190141,
                "headline": "RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform Recommendation"
              },
              {
                "id": 141279874,
                "url": "https://finnhub.io/api/news?id=71e8053143691ce56fa051f1633b66dd2fc4e0397c0f77a7befeda58c6e547db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers & services stocks fared in Q2, starting with McKesson (NYSE:MCK).",
                "category": "company",
                "datetime": 1787146682,
                "headline": "Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks"
              },
              {
                "id": 141157482,
                "url": "https://finnhub.io/api/news?id=0a358d781b15edfdd9e8d08f722aa5155ec12f731cd9f35d61f78a4ed69b80a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running share repurchase program and raised adjusted earnings guidance, highlighting management’s confidence in specialty and oncology growth, technology and AI investments, and the...",
                "category": "company",
                "datetime": 1786180297,
                "headline": "How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story"
              },
              {
                "id": 141149554,
                "url": "https://finnhub.io/api/news?id=05b594034734df0805d0360650dd626b9ea4065fe219f8f657040e1aac0a900c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) could produce exceptional returns because of its solid growth attributes.",
                "category": "company",
                "datetime": 1786121103,
                "headline": "McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why"
              },
              {
                "id": 141137317,
                "url": "https://finnhub.io/api/news?id=800e586663a06c21846fb4704cde171e522540f493e9141574d3def76d3d7334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.",
                "category": "company",
                "datetime": 1786030860,
                "headline": "MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised"
              },
              {
                "id": 141135594,
                "url": "https://finnhub.io/api/news?id=688c9cef3366902114ebb4a2dd2eead7afd75544ec841ba4439fd53ddcd80354",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.",
                "category": "company",
                "datetime": 1786024800,
                "headline": "MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise"
              }
            ],
            "raw_source": [
              {
                "id": 141279873,
                "url": "https://finnhub.io/api/news?id=3767b39289f961b23b4cea0a3fc907e9f9236de7fa29f9ab8b87d5a591e7449f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...",
                "category": "company",
                "datetime": 1787275175,
                "headline": "McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up"
              },
              {
                "id": 141279875,
                "url": "https://finnhub.io/api/news?id=f6035c2fee2c59ca1eaac8e5da967b709784076bca00286133a3da05dae0cb0b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...",
                "category": "company",
                "datetime": 1787256543,
                "headline": "McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?"
              },
              {
                "id": 141261329,
                "url": "https://finnhub.io/api/news?id=0bcc4b756c6d1ebb9c1d9f3ee76fbdf22f5f0eca89a7e45fd098bfb7d6ddce91",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157585497/image_2157585497.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Net of fees, GRW delivered a return of +17.32% in Q2 2026, compared to the S&P 500 Index's return of +15.20%.",
                "category": "company",
                "datetime": 1787217000,
                "headline": "TCW Durable Growth ETF Q2 2026 Performance Update"
              },
              {
                "id": 141258800,
                "url": "https://finnhub.io/api/news?id=bdb7e234a55d9cb334bafa47adbce8dc37ba2ded4a75ace86531b8150354fc20",
                "image": "",
                "source": "Fintel",
                "related": "MCK",
                "summary": "",
                "category": "company",
                "datetime": 1787190141,
                "headline": "RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform Recommendation"
              },
              {
                "id": 141279876,
                "url": "https://finnhub.io/api/news?id=80e2683d6b03e9856102f88928d0b33f293bf6830fce12c7e49c75c925df79ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.",
                "category": "company",
                "datetime": 1787157180,
                "headline": "Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?"
              },
              {
                "id": 141255098,
                "url": "https://finnhub.io/api/news?id=407cd590acc44067e69ec21c3b5d573dbff31e348a254be4edac3e8cfcac88f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1787150302,
                "headline": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141279874,
                "url": "https://finnhub.io/api/news?id=71e8053143691ce56fa051f1633b66dd2fc4e0397c0f77a7befeda58c6e547db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare providers & services stocks fared in Q2, starting with McKesson (NYSE:MCK).",
                "category": "company",
                "datetime": 1787146682,
                "headline": "Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks"
              },
              {
                "id": 141257551,
                "url": "https://finnhub.io/api/news?id=f6172b7c49124c0d4ec9fce8c5738b4d9d405e7db8353fc6b685e4509c75e306",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Barclays  analyst Glen Santangelo   maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $925 to $1000.",
                "category": "company",
                "datetime": 1787134773,
                "headline": "Barclays Maintains Overweight on McKesson, Raises Price Target to $1000"
              },
              {
                "id": 141257552,
                "url": "https://finnhub.io/api/news?id=6be89915164eaea69f703cb5c151a416184f8f61bf8d3c61215b0822d48fd47d",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "RBC Capital  analyst Ryan Halsted   initiates coverage on McKesson (NYSE:MCK) with a Sector Perform rating and announces Price Target of $845.",
                "category": "company",
                "datetime": 1787133051,
                "headline": "RBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845"
              },
              {
                "id": 141279877,
                "url": "https://finnhub.io/api/news?id=c47505c3dc9586b3a6348210ab896b422c8c06eda61b4c18fa117bc974b4f9e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.",
                "category": "company",
                "datetime": 1787077380,
                "headline": "OPKO Health Secures $125 Million Financing Against Mazdutide Royalties"
              },
              {
                "id": 141223241,
                "url": "https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.",
                "category": "company",
                "datetime": 1786740389,
                "headline": "AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141237778,
                "url": "https://finnhub.io/api/news?id=367a84c2f8076f5a8bad9804ededf729b3319df5dfda2f5bb74e17f5d37735d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.",
                "category": "company",
                "datetime": 1786725360,
                "headline": "Reasons to Hold Hinge Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141237779,
                "url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
                "category": "company",
                "datetime": 1786725300,
                "headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
              },
              {
                "id": 141215404,
                "url": "https://finnhub.io/api/news?id=beb9b099af96d85f171d75a1ec7e33b07f1b4f81a4d3a80843d5472a77c0205e",
                "image": "",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "",
                "category": "company",
                "datetime": 1786685700,
                "headline": "Allspring Large Cap Growth Fund Q2 2026 Performance Update"
              },
              {
                "id": 141200621,
                "url": "https://finnhub.io/api/news?id=a08e7c7fa18be82606ea2feeb7ddeeada1626fe5e95e301c926252196ccedab8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie commands a premium valuation for its specialty drug pipeline, while CVS Health trades at a discount despite managing 37 million medical members.",
                "category": "company",
                "datetime": 1786481221,
                "headline": "AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141201489,
                "url": "https://finnhub.io/api/news?id=e53a74fb978cb94b10738c9262b2a96baa6fac4eef3538f1a98cc3c9da000745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment. For the q",
                "category": "company",
                "datetime": 1786467870,
                "headline": "Cardinal Health Q4 Earnings Call Highlights"
              },
              {
                "id": 141201490,
                "url": "https://finnhub.io/api/news?id=b27d87e3c8947f158bf4d832fe91f3e13a1b1c088d17bd7f1566ddeb622996ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall.  Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point.  Cencora, another big S&P 500 drug distributor, also is near a buy point, but MCK stock may be the strongest of the three.",
                "category": "company",
                "datetime": 1786454176,
                "headline": "S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results"
              },
              {
                "id": 141185344,
                "url": "https://finnhub.io/api/news?id=36e70aefff215f1037c8bea30b9efe2b8c455a038d191cea49c8576b1e70276b",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains McKesson (NYSE:MCK) with a Equal-Weight and raises the price target from $812 to $933.",
                "category": "company",
                "datetime": 1786438791,
                "headline": "Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933"
              },
              {
                "id": 141177635,
                "url": "https://finnhub.io/api/news?id=2e87455abaf1fa312c423f3bfe57322bf443a81c6e419773c587559f5d9f5133",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.",
                "category": "company",
                "datetime": 1786382940,
                "headline": "QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered"
              },
              {
                "id": 141177636,
                "url": "https://finnhub.io/api/news?id=ffdfab5d91e411887bc6414fe5e00badc391012530468522e6572447588ee92f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.",
                "category": "company",
                "datetime": 1786382820,
                "headline": "Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline"
              },
              {
                "id": 141160721,
                "url": "https://finnhub.io/api/news?id=4d55152f0db1c1fa5527adfeaf586f1bb8bf0d0827f7c70061f163d0723eb98f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook. Revenue rose 8% to $105.4 billion, while adjuste",
                "category": "company",
                "datetime": 1786212231,
                "headline": "McKesson Q1 Earnings Call Highlights"
              },
              {
                "id": 141158590,
                "url": "https://finnhub.io/api/news?id=e1de4277f5c22ac4c0037ee71ee9c2226bd01f2d336d1abf5c27b1908b45915c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305098938/image_1305098938.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Weekly dividend stock update: 24 hikes, 1 cut. Read to see top raises like FIX & MCK, HONâs spinoff impact, and how to spot safe income.",
                "category": "company",
                "datetime": 1786184967,
                "headline": "Dividend Announcements: July 18-24, 2026"
              },
              {
                "id": 141157482,
                "url": "https://finnhub.io/api/news?id=0a358d781b15edfdd9e8d08f722aa5155ec12f731cd9f35d61f78a4ed69b80a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running share repurchase program and raised adjusted earnings guidance, highlighting management’s confidence in specialty and oncology growth, technology and AI investments, and the...",
                "category": "company",
                "datetime": 1786180297,
                "headline": "How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story"
              },
              {
                "id": 141157906,
                "url": "https://finnhub.io/api/news?id=fab1c782cbda61816d37a0ae7c11e896000944385900ca33ac459cfdbb26e466",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230977259/image_2230977259.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson's Q1 earnings: EPS up 20%, revenue +7.7%, FY27 guidance raised. Click here to read more about MCK.",
                "category": "company",
                "datetime": 1786176000,
                "headline": "McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)"
              },
              {
                "id": 141152474,
                "url": "https://finnhub.io/api/news?id=3852ba4223d6f6fd4381be34a82f8c1b6dd45b23181cf2e6ab311afb3d93f615",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.",
                "category": "company",
                "datetime": 1786135497,
                "headline": "AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141151124,
                "url": "https://finnhub.io/api/news?id=d7465a2a4c88ee05863f3b79d5beec80125a4c5b3f1728075ee3ed1c26c3ad57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.",
                "category": "company",
                "datetime": 1786126800,
                "headline": "Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?"
              },
              {
                "id": 141151125,
                "url": "https://finnhub.io/api/news?id=0854f9893f7e0124ebd598160832596723151b50db3780060288d2e8256a7c06",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.",
                "category": "company",
                "datetime": 1786125420,
                "headline": "10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up"
              },
              {
                "id": 141151126,
                "url": "https://finnhub.io/api/news?id=cfab742cf05cd6088afc2f50d6af7fb553f338ccdbaf70bfd1cdcd0559e40570",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "RGTI's Q2 revenues surge 185.3% and beat estimates, but widening losses and higher R&D and SG&A costs continue to pressure profitability.",
                "category": "company",
                "datetime": 1786125300,
                "headline": "Rigetti Q2 Earnings Miss Estimates on Higher Costs, Revenue Beat"
              },
              {
                "id": 141149554,
                "url": "https://finnhub.io/api/news?id=05b594034734df0805d0360650dd626b9ea4065fe219f8f657040e1aac0a900c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) could produce exceptional returns because of its solid growth attributes.",
                "category": "company",
                "datetime": 1786121103,
                "headline": "McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why"
              },
              {
                "id": 141159495,
                "url": "https://finnhub.io/api/news?id=9ffb7fecb0f501883098779ae65df01fc0dcd39cc25eb11b2d6bf358942a43ff",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.04% on an annualized basis producing an average annual return of 34.84%. Currently, McKesson has a market capitalization of $101.38 billion.",
                "category": "company",
                "datetime": 1786119325,
                "headline": "$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 141148240,
                "url": "https://finnhub.io/api/news?id=1def74c37e95fb5383501555aa63fc8a7abb1562fe6f79afae08e538c51ffed9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1786108503,
                "headline": "Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 141140627,
                "url": "https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.",
                "category": "company",
                "datetime": 1786038780,
                "headline": "Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 141140628,
                "url": "https://finnhub.io/api/news?id=a8b9dcae545cc5c62870f85c5a89bc5758dc075833203dde38abaea6245b92f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.",
                "category": "company",
                "datetime": 1786035840,
                "headline": "PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut"
              },
              {
                "id": 141137316,
                "url": "https://finnhub.io/api/news?id=f23c7f57565c87589923985dcfb23a36115479fe932f711cc0df05b80818daf2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.",
                "category": "company",
                "datetime": 1786033860,
                "headline": "LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised"
              },
              {
                "id": 141147900,
                "url": "https://finnhub.io/api/news?id=e42c57bcc23d4c025cac49bfa0346608180e95cfd8fa94993d84f176c4078ee0",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "TD Cowen  analyst Charles Rhyee   maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $989 to $1006.",
                "category": "company",
                "datetime": 1786031449,
                "headline": "TD Cowen Maintains Buy on McKesson, Raises Price Target to $1006"
              },
              {
                "id": 141137317,
                "url": "https://finnhub.io/api/news?id=800e586663a06c21846fb4704cde171e522540f493e9141574d3def76d3d7334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.",
                "category": "company",
                "datetime": 1786030860,
                "headline": "MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised"
              },
              {
                "id": 141147901,
                "url": "https://finnhub.io/api/news?id=57909521d0c5f1ad27c8c7cd26201167f0969b5d46730032b4eb69edeb502361",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "UBS  analyst Kevin Caliendo   maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $1050 to $1080.",
                "category": "company",
                "datetime": 1786030450,
                "headline": "UBS Maintains Buy on McKesson, Raises Price Target to $1080"
              },
              {
                "id": 141135594,
                "url": "https://finnhub.io/api/news?id=688c9cef3366902114ebb4a2dd2eead7afd75544ec841ba4439fd53ddcd80354",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.",
                "category": "company",
                "datetime": 1786024800,
                "headline": "MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise"
              },
              {
                "id": 141134168,
                "url": "https://finnhub.io/api/news?id=43b6a86813caef07467b33bc73f0cc2783705a8dc341743143ddb802b51d6bfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "NEW YORK, August 06, 2026--Leap, the healthcare company making specialty medicine more affordable and easier to access, today announced the appointment of Christine Hummel as Senior Vice President of Manufacturer and Specialty Network Partnerships. In this role, she will lead Leap's strategy and partnerships across pharmaceutical manufacturers and specialty care networks, helping expand access to specialty therapies through more transparent and efficient models of care.",
                "category": "company",
                "datetime": 1786021200,
                "headline": "Leap Expands Manufacturer & Specialty Network Partnerships with Appointment of Industry Executive Christine Hummel"
              },
              {
                "id": 141137787,
                "url": "https://finnhub.io/api/news?id=a73436ca295abf1de7d9c8dd5ce945af1b0ef6be9e55b065e2e5fc02892b7749",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Evercore ISI Group  analyst Elizabeth Anderson   maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $860 to $1000.",
                "category": "company",
                "datetime": 1786015827,
                "headline": "Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1000"
              },
              {
                "id": 141131696,
                "url": "https://finnhub.io/api/news?id=5e849f33a30c41b4ca74705591359f68c72fb6a6dd8b4a7c2d3d78f79efec312",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson Corp (MCK) delivered an 8% revenue increase to $105.4 billion and a 20% adjusted EPS surge, prompting a full-year guidance raise and a 15% dividend boost.",
                "category": "company",
                "datetime": 1785993296,
                "headline": "McKesson Corp (MCK) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth and Raised ..."
              },
              {
                "id": 141130794,
                "url": "https://finnhub.io/api/news?id=0a850ca78cc7e37d25c8f624d58ecd116d71c8379534dab0cb095f3248372dfe",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "2026-08-05. The following slide deck was published by McKesson Corporation in conjunction with their 2027 Q1 earnings call.",
                "category": "company",
                "datetime": 1785972649,
                "headline": "McKesson Corporation 2027 Q1 - Results - Earnings Call Presentation"
              },
              {
                "id": 141129269,
                "url": "https://finnhub.io/api/news?id=ff081edfb0df7029814b96a8f351f77f0883e8cf8768832ad40be18385153566",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) delivered earnings and revenue surprises of +5.19% and +0.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785967816,
                "headline": "McKesson (MCK) Q1 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141129271,
                "url": "https://finnhub.io/api/news?id=cf6cc63b667f0870660b51f8e2e87fbf1a3579d7836911847ae6330c723cc033",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
                "category": "company",
                "datetime": 1785967203,
                "headline": "McKesson (MCK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates"
              },
              {
                "id": 141129972,
                "url": "https://finnhub.io/api/news?id=9f59631d212bc4e1f1055fc6d749a0785b9d8187697a5d4c2afa491afc330b9a",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "McKesson Corporation (MCK) Q1 2027 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsPaula AdkisonBrian Tyler - CEO & ChairmanKenny Cheung -...",
                "category": "company",
                "datetime": 1785966004,
                "headline": "McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript"
              },
              {
                "id": 141126827,
                "url": "https://finnhub.io/api/news?id=0c31fe0b2d0caab81d508e5fdaea005a58287c2047d6405ce71ba4ef83761794",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "MCK",
                "summary": "As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.",
                "category": "company",
                "datetime": 1785963901,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's after-hours session."
              },
              {
                "id": 141127546,
                "url": "https://finnhub.io/api/news?id=bcecb40436a3b28ccff2c7297ffeaa92d90921bca447a797e27b95e6d18108d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Healthcare distributor and services company McKesson (NYSE:MCK) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.7% year on year to $105.4 billion. Its non-GAAP profit of $9.93 per share was 4.1% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785961145,
                "headline": "McKesson’s (NYSE:MCK) Q2 CY2026 Sales Top Estimates"
              },
              {
                "id": 141127547,
                "url": "https://finnhub.io/api/news?id=abf8dbc88f5894982fb638c2fb3764b940a7daae809e5be48fce0e666ccc4989",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "IRVING, Texas, August 05, 2026--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.",
                "category": "company",
                "datetime": 1785960600,
                "headline": "McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance"
              },
              {
                "id": 141125706,
                "url": "https://finnhub.io/api/news?id=323e5a3f9c5dd535eafdd88ad8552039eeecd9956c9b18925cca11db56bff5ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A few sectors have dominated the market this year, and healthcare isn’t one of them. Many stocks in the sector look ready to gain.",
                "category": "company",
                "datetime": 1785958260,
                "headline": "Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy."
              },
              {
                "id": 141125845,
                "url": "https://finnhub.io/api/news?id=1f072d8bc81262c58fcde9ca14f0cd390a156475a76a63fa82afa3bf37326bfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.",
                "category": "company",
                "datetime": 1785951720,
                "headline": "TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract"
              },
              {
                "id": 141124354,
                "url": "https://finnhub.io/api/news?id=3c99f0ca4df1360198bfda8776337250d51ac456a32bc832bac0b78ca6f14858",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance reinforce business momentum.",
                "category": "company",
                "datetime": 1785948000,
                "headline": "HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up"
              },
              {
                "id": 141128229,
                "url": "https://finnhub.io/api/news?id=3a61b69f67aa929b9980aa22c17447a78ed891765ef84087244fc7252e7c0df0",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 analyst estimate. sees sales of $423.601 billion-$439.739 billion vs $431.419 billion analyst estimate.",
                "category": "company",
                "datetime": 1785946367,
                "headline": "McKesson Raises FY2027 Adj EPS Guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 Est; Sees Sales $423.601B-$439.739B vs $431.419B Est"
              },
              {
                "id": 141128230,
                "url": "https://finnhub.io/api/news?id=a7cb6eb9aa91c66396e41a053e3ae42514dc2810013c434a74592a0bcf5fa5bc",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "McKesson (NYSE:MCK) reported quarterly earnings of $9.93 per share which beat the analyst consensus estimate of $9.54 by 4.09 percent. This is a 20.22 percent increase over earnings of $8.26 per share from the same",
                "category": "company",
                "datetime": 1785946294,
                "headline": "McKesson Q1 Adj. EPS $9.93 Beats $9.54 Estimate, Sales $105.380B Beat $103.738B Estimate"
              },
              {
                "id": 141122656,
                "url": "https://finnhub.io/api/news?id=026d8fb37247e734556ab139d7617d44722f4e154e1c54607e4041ad152a13a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.",
                "category": "company",
                "datetime": 1785941400,
                "headline": "COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised"
              },
              {
                "id": 141122657,
                "url": "https://finnhub.io/api/news?id=d65126c035551814d108e50a1313d81a1237d5b5ba6733964cc3b8dad767605a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.",
                "category": "company",
                "datetime": 1785941340,
                "headline": "FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand"
              },
              {
                "id": 141121177,
                "url": "https://finnhub.io/api/news?id=23e6ddf098968bb77ad4c266e778419394fc5af585454c4207229c455f8f2bdd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "The benchmark US stock measures were trending higher in Wednesday's premarket activity amid growing",
                "category": "company",
                "datetime": 1785932158,
                "headline": "Stocks Rise Pre-Bell Amid Growing Hopes for Hormuz Deal; Traders Await More Corporate Earnings"
              },
              {
                "id": 141114964,
                "url": "https://finnhub.io/api/news?id=3a27c79bdda7dbd1818b7e5a6ed33774efec5c2b5603c9fd4a49454d569f3183",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Revvity beats Q2 earnings and sales estimates as Diagnostics growth, wider margins and strong cash flow support a higher 2026 outlook.",
                "category": "company",
                "datetime": 1785870540,
                "headline": "RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up"
              },
              {
                "id": 141114965,
                "url": "https://finnhub.io/api/news?id=a76269cd0057c2594211e58ca0d57d39fd42fa56d0cd555210da965d1354395d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.",
                "category": "company",
                "datetime": 1785870480,
                "headline": "What's in Store for These 4 Healthcare Companies This Earnings Season?"
              },
              {
                "id": 141113306,
                "url": "https://finnhub.io/api/news?id=93e3024cc729afbadc0388f46416383251b5c154792cb2c44fa43872b0efef0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, policy and integration risks test the rebound case.",
                "category": "company",
                "datetime": 1785864120,
                "headline": "BTSG Drops 18.1% in One Week as Growth Meets Fresh Valuation Risks"
              },
              {
                "id": 141112034,
                "url": "https://finnhub.io/api/news?id=29220b2023579682d098f84e1a9bd930eeb6b970fa72c6152de3c809aefed06f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.",
                "category": "company",
                "datetime": 1785862680,
                "headline": "Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up"
              },
              {
                "id": 141103123,
                "url": "https://finnhub.io/api/news?id=956f1718fa4a9368b5b1e1c2d0314e3d2f1156a72ea5cdc41fba63ace48f774f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as pricing dynamics may temper revenues.",
                "category": "company",
                "datetime": 1785783300,
                "headline": "Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?"
              },
              {
                "id": 141101012,
                "url": "https://finnhub.io/api/news?id=997f5ef6b2549b82d642e99554c1aea576c8afc47908049915f352f11bb26752",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "BTSG's Q2 earnings and revenues beat estimates as pharmacy and provider growth drive margin gains and a higher 2026 outlook.",
                "category": "company",
                "datetime": 1785773520,
                "headline": "BrightSpring Q2 Earnings Beat on Specialty Growth, '26 View Raised"
              },
              {
                "id": 141108755,
                "url": "https://finnhub.io/api/news?id=a08b99fb7096703dfb31cfc5e4f1ad7c2d68a1f75c321c5bf42201e21fe53b69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson, Encompass Health and Omega Healthcare Investors raised dividends, with payout ratios and yields showing varying levels of sustainability across the healthcare sector.",
                "category": "company",
                "datetime": 1785764700,
                "headline": "3 Healthcare Stocks With Fresh Dividend Hikes and Different Income Profiles"
              },
              {
                "id": 141090737,
                "url": "https://finnhub.io/api/news?id=4485177046a32c74935a58c2263e20d35d6b0f20123beaf5636edf36703d37c2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1217747083/image_1217747083.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Altria Group is poised to announce its 56th consecutive annual dividend increase in August. Check out the dividend increases here.",
                "category": "company",
                "datetime": 1785624101,
                "headline": "Altria Among 7 Dividend Kings To Announce Annual Dividend Increases In August"
              },
              {
                "id": 141092901,
                "url": "https://finnhub.io/api/news?id=1cc922ced795d9da440e685882a8ed10b093e94b40fc4102622ab8df73130eda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A weekly roundup covering Magnificent Seven earnings, Fed rate pauses, U.S.-Iran tensions, and MarketBeat analysts' takes on stocks including Microsoft, Alphabet, Broadcom, Tesla, and UnitedHealth.",
                "category": "company",
                "datetime": 1785582000,
                "headline": "MarketBeat Week in Review – 07/27- 07/31"
              },
              {
                "id": 141082663,
                "url": "https://finnhub.io/api/news?id=b33047fe895cae4d7a41b3346f7bc9c963ecde60ea4abc0a175bec3123356b5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "BCE (TSX: BCE) (NYSE: BCE) today announced the appointment of Rebecca McKillican as a director of BCE Inc. and Bell Canada.",
                "category": "company",
                "datetime": 1785528900,
                "headline": "Rebecca McKillican joins the Board of Directors of BCE Inc."
              },
              {
                "id": 141081614,
                "url": "https://finnhub.io/api/news?id=d255bc31c026370e4f43efbdda0092a70757d40c305c682c668d4ecc02048759",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.",
                "category": "company",
                "datetime": 1785519660,
                "headline": "DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise"
              },
              {
                "id": 141080381,
                "url": "https://finnhub.io/api/news?id=c1245c5746c22ff46ef9ac1ca560e75935767219c3b020b02059cac810c7e881",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.",
                "category": "company",
                "datetime": 1785510480,
                "headline": "MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised"
              },
              {
                "id": 141079102,
                "url": "https://finnhub.io/api/news?id=693d7da201dd6ee1737f170709fd5edad838d6fb56b43a75a77dcfa9ba5d0007",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.",
                "category": "company",
                "datetime": 1785504660,
                "headline": "SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery"
              },
              {
                "id": 141079111,
                "url": "https://finnhub.io/api/news?id=1075a796802e71cf0015696da984fb33e290de2ef9e726d4e035ee3fe6f87cab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Get a deeper insight into the potential performance of McKesson (MCK) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
                "category": "company",
                "datetime": 1785503702,
                "headline": "Curious about McKesson (MCK) Q1 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141072969,
                "url": "https://finnhub.io/api/news?id=a800a1b5e3d0fd3cee3e94630f0ecf458df676d9d35e60bcfa5793e773f0ebcf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "In the most recent trading session, McKesson (MCK) closed at $865.51, indicating a -2.59% shift from the previous trading day.",
                "category": "company",
                "datetime": 1785448205,
                "headline": "McKesson (MCK) Stock Dips While Market Gains: Key Facts"
              },
              {
                "id": 141069866,
                "url": "https://finnhub.io/api/news?id=0dfe3261d572d799bd0afc21d1b7620e68822a55e077b34e774063c0083f6990",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.",
                "category": "company",
                "datetime": 1785430140,
                "headline": "CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands"
              },
              {
                "id": 141068410,
                "url": "https://finnhub.io/api/news?id=158f7b2c996c478551835b9450571218c59e03e29195ae6524c63f0ad04ffc1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.",
                "category": "company",
                "datetime": 1785429960,
                "headline": "Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised"
              },
              {
                "id": 141068411,
                "url": "https://finnhub.io/api/news?id=0007ffe0216e700b6c8ed0b3e1049e7206b7730a714da3b4daae9f8b75ec010f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.",
                "category": "company",
                "datetime": 1785427320,
                "headline": "BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract"
              },
              {
                "id": 141068412,
                "url": "https://finnhub.io/api/news?id=cc292e3b8f12ff007275fcb1af654d34bc6fe0a8a71b1d867b4bfd95cdd330fc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "GKOS' Q2 loss narrows as revenues jump 50% on iDose TR and Epioxa growth, lifting its 2026 sales outlook and shares by 9.8%.",
                "category": "company",
                "datetime": 1785426900,
                "headline": "Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up"
              },
              {
                "id": 141059800,
                "url": "https://finnhub.io/api/news?id=b145bdf9f5394b56227ec59e5e7b0f8bff3a4c840be8118d8207d93894c18a09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Align Technology (ALGN) delivered earnings and revenue surprises of +3.13% and +0.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785360302,
                "headline": "Align Technology (ALGN) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141055862,
                "url": "https://finnhub.io/api/news?id=d2c593c9349957b3ca16152323c967c4417d3ab3f9db8797978f488a55bb6f6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.",
                "category": "company",
                "datetime": 1785339720,
                "headline": "GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 141055863,
                "url": "https://finnhub.io/api/news?id=dc6b208f3d8cb61b19b3c297a8cc56c2951996a4af7af738c66e92cd98982229",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.",
                "category": "company",
                "datetime": 1785337380,
                "headline": "Here's Why You Should Retain DaVita Stock in Your Portfolio for Now"
              },
              {
                "id": 141054255,
                "url": "https://finnhub.io/api/news?id=c07c6878fb8ef451d86fccafb8bd6bcd12ec58f8373bdf0ea9da5520bdc03e5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785333626,
                "headline": "McKesson (MCK) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 141046401,
                "url": "https://finnhub.io/api/news?id=32ad537cf749428c45d48370b3a6ea3ee5ef6bbb0ca881255ba5054d1decc3b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "ECL stock rises pre-market after earnings and revenues beat estimates, as pricing, volume growth and core-business demand lift organic sales.",
                "category": "company",
                "datetime": 1785257820,
                "headline": "Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market"
              },
              {
                "id": 141046402,
                "url": "https://finnhub.io/api/news?id=6a65cd8bb4225e38749850240bc29db3c65aae000cf5cf660f47852c738148f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lift shares pre-market.",
                "category": "company",
                "datetime": 1785257700,
                "headline": "OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 141033957,
                "url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
                "category": "company",
                "datetime": 1785160469,
                "headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
              },
              {
                "id": 141033964,
                "url": "https://finnhub.io/api/news?id=fd308767b5de2c6bbd78aa55718c495e1be0694fd3a2087679a5015086eaaedb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1785159003,
                "headline": "Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?"
              },
              {
                "id": 141033965,
                "url": "https://finnhub.io/api/news?id=5d7090a4fb695f255effb47da586d72dcf54b4a024ad6a80984d2819806eaa0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.",
                "category": "company",
                "datetime": 1785158640,
                "headline": "MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access"
              },
              {
                "id": 141020306,
                "url": "https://finnhub.io/api/news?id=73ec387978594516cefd80c1f0e8166176ea7c11b61ab76ccd49db0b05476065",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson (MCK) has announced a quarterly dividend of $0.94 per share, payable on October 1, 2026. Both the ex dividend and record dates are set for September 1, 2026, drawing fresh attention to the stock. See our latest analysis for McKesson. At a latest share price of $840.90, McKesson has seen a 1 day share price return of 1.99% and a 1 month share price return of 9.70%, while its 1 year total shareholder return of 18.61% and 5 year total shareholder return of 323.86% indicate solid longer...",
                "category": "company",
                "datetime": 1785020887,
                "headline": "McKesson (MCK) Declares Quarterly Dividend, Is The Stock Still Undervalued?"
              },
              {
                "id": 141015640,
                "url": "https://finnhub.io/api/news?id=cfff6f73a99eed00740246c232ba2122851845a21a2f029f0288fd135c2935e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "McKesson stock has logged a very strong 323.9% return over the past five years, yet the latest valuation checks still flag it as screening on the cheap side. This raises the question of how much of the story is already reflected in the current US$840.90 share price. Over five years, McKesson has returned 323.9%, which puts long term holders in a strong position and makes today’s entry point more sensitive to the valuation starting point. For valuation, the key support is the company’s role...",
                "category": "company",
                "datetime": 1784977846,
                "headline": "McKesson (MCK) Stock May Still Be A Bargain After A 324% Run"
              },
              {
                "id": 141014631,
                "url": "https://finnhub.io/api/news?id=260949078611a1976e37ca06fdaa7e41273b6effb3c5ecf71d425036d789c368",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "Earlier this week, McKesson Corporation announced a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend and record date. This higher payout highlights how McKesson is combining dividend growth with its existing share repurchase efforts, reinforcing management’s confidence in the company’s earnings power. Against this backdrop of a higher quarterly dividend, we’ll now examine how the announcement interacts with...",
                "category": "company",
                "datetime": 1784959804,
                "headline": "Rising Dividend and Buybacks Might Change The Case For Investing In McKesson (MCK)"
              },
              {
                "id": 141011008,
                "url": "https://finnhub.io/api/news?id=2b5681c8ad3445c10d7b6b93b6c6f3bb5e4d97717a3b68cc3433f7ac9b353349",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MCK",
                "summary": "Get the weekly dividend update for Champions, Contenders & Challengersâread about the dividend changes, upcoming ex-dividend dates and pay dates here.",
                "category": "company",
                "datetime": 1784916411,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of July 26"
              },
              {
                "id": 141011728,
                "url": "https://finnhub.io/api/news?id=5aebcf7f9b3006eddba94bd090b7f1e841c15c773ab1a11b67e7a7db30d25b13",
                "image": "",
                "source": "Benzinga",
                "related": "MCK",
                "summary": "Citigroup  analyst Daniel Grosslight   maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $945 to $1000.",
                "category": "company",
                "datetime": 1784906497,
                "headline": "Citigroup Maintains Buy on McKesson, Raises Price Target to $1000"
              },
              {
                "id": 141007920,
                "url": "https://finnhub.io/api/news?id=87f8d85494584027365a3886769e86bfba2dbfdaab5bcc5ff6b64728ff179ba8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.",
                "category": "company",
                "datetime": 1784905740,
                "headline": "Here's Why You Should Add Cencora Stock to Your Portfolio Now"
              },
              {
                "id": 141007921,
                "url": "https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MCK",
                "summary": "RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.",
                "category": "company",
                "datetime": 1784905500,
                "headline": "Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.5,
            "source_article_count": 91,
            "discarded_article_count": 70
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.7,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.6,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.6,
            "vcp_reason": "波幅收縮(14.2%→7.4%)；站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 952933.3333333334,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 913170,
              "avg_vol_20": 1011930,
              "avg_vol_30": 952933.3333333334,
              "range_pct_10": 0.07374544944125161,
              "range_pct_20": 0.11831411996008569,
              "range_pct_30": 0.14196063239118328,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9582727018329369,
              "dist_to_20d_high": 0.058739704109588994,
              "down_shrink_days": 2,
              "breakout_level_20d": 912.5,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5194781693986854
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.5,
            "details": {
              "atrPct": 3.4010244871108513,
              "turnoverUsdM": 1357.577371612,
              "liquidityPoints": 0.8,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MCK",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 800.4772,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.8,
            "take_profit_price": 919.0268,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 7
          },
          "positionPoints": 1.5,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.8020489742217025,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 29.2114,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.4
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -50.82
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1294
    },
    "kdj": {
      "d": 34.13,
      "j": 8.57,
      "k": 25.61,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 57.41
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -4850000,
      "recentSlope": -110340,
      "previousSlope": -256640
    },
    "rsi": 57.34,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 824.4859,
      "position": "SAR喺價下",
      "distancePct": 4.01,
      "previousTrend": "上升"
    },
    "ma50": 821.252,
    "macd": {
      "macd": 9.439805457747866,
      "trend": "中性偏多",
      "signal": 14.601969653618955,
      "histogram": -5.162164195871089
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 865.5648,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.51,
      "score": 6,
      "avgVolume": 1049770,
      "currentVolume": 1580600
    },
    "derived": {
      "ma20": 864.609,
      "ma50": 821.252,
      "prevClose": 838.75,
      "avgVolume10": 915010,
      "avgVolume20": 1049770,
      "changePercent": 2.4,
      "avgVolumeForScore": 1049770
    },
    "ma_cross": {
      "ma20": 864.609,
      "ma50": 821.252,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 863.709,
      "prevMa50": 819.8828,
      "spreadPct": 5.28,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 827.0924,
      "upper": 902.1256,
      "position": "中間"
    },
    "rsi_short": 51.36,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.51
    }
  }
}

Raw metrics JSON

{
  "close": 858.9,
  "volume": 1580600,
  "changePercent": 2.4
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.MCK · McKesson Corporation

觀望

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 3.6/5 · 良好

Sub-items

資金流 — 10/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 8.2/15 · 較差

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 10/20 · 較差

Sub-items

catalyst

details

風險管理 — 6.7/10 · 一般

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 19.7/30 · 一般

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 6/10 · 一般

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON